C. Aluise

发表

Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.

D. Butterfield, R. Sultana, D. S. St. Clair, 2010, Advances in experimental medicine and biology.

In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE).

D. Butterfield, D. S. St. Clair, M. Vore, 2009, Cancer letters.

Site-Specific, Intramolecular Cross-Linking of Pin1 Active Site Residues by the Lipid Electrophile 4-Oxo-2-nonenal

Kristie L. Rose, L. Marnett, J. Galligan, 2015, Chemical research in toxicology.

Potential in vivo amelioration by N‐acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: Toward therapeutic modulation of mild cognitive impairment

D. Butterfield, R. Sultana, W. Markesbery, 2010, Journal of neuroscience research.

Acetyl-l-Carnitine and Ferulic Acid Action in Aging and Neurodegenerative Diseases

D. Butterfield, Renã, A. Sowell, 2009 .

Peptidyl-prolyl cis/trans-Isomerase A1 (Pin1) Is a Target for Modification by Lipid Electrophiles

Michelle L. Reyzer, Kristie L. Rose, L. Marnett, 2012, Chemical research in toxicology.

2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.

D. Butterfield, R. Sultana, Jian Cai, 2011, Free radical biology & medicine.

Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.

D. Butterfield, Jian Cai, W. Pierce, 2011, Journal of Alzheimer's disease : JAD.

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

D. Butterfield, Renã A. Sowell, C. Aluise, 2008, Biochimica et biophysica acta.

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

D. Butterfield, R. Sultana, G. Joshi, 2010, Neuroscience.

Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical Species

R. Dean, D. McKinzie, L. L. Winneroski, 2022, Journal of Alzheimer's disease reports.

Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814).

J. Schumi, J. Mullen, A. Wessels, 2017, The journal of prevention of Alzheimer's disease.

Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics

D. Butterfield, Jian Cai, W. Pierce, 2010, Neurobiology of Disease.

Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

D. Butterfield, W. Banks, R. Sultana, 2010, Free radical biology & medicine.

Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor.

D. McKinzie, D. Timm, L. L. Winneroski, 2021, Journal of medicinal chemistry.

Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.

D. Butterfield, Jian Cai, W. Pierce, 2011, Journal of Alzheimer's disease : JAD.

In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE).

D. S. St. Clair, M. Vore, C. Aluise, 2009, Cancer letters.